Lantheus Medical Imaging: Data Featuring Gadofosveset Trisodium, the First and Only MRA Blood Pool Agent Approved in The U.S., Presented At MRA-Club 09: The 21st Annual International Conference on Magnetic Resonance Angiography
10/8/2009 9:11:09 AM
More...
|
Lantheus Medical Imaging Announces FDA And Health Canada Approval Of Australian Nuclear Science And Technology Organisation (Ansto)-Supplied Key Medical Isotope To Manufacture Technelite(R) Generator
7/9/2009 11:14:21 AM
More...
|
Scientists Who Made Significant Contribution to Discovery of Lantheus Medical Imaging's Cardiolite(R) Honored with Prestigious Nuclear Medicine Award at SNM Annual Meeting
6/15/2009 9:54:51 AM
More...
|
Lantheus Medical Imaging: BARI 2D Study Presented at American Diabetes Association Scientific Sessions Underscores Utility of SPECT Myocardial Perfusion Imaging in Identifying Cardiovascular Risk and Evaluating Treatment Outcomes for Patients with Type 2 Diabetes
6/12/2009 9:07:49 AM
More...
|
Lantheus Medical Imaging: SPECT MPI with Cardiolite(R) Used in BARI 2D Study to Evaluate Type 2 Diabetes and Coronary Artery Disease Treatment Strategies
6/4/2009 10:29:18 AM
More...
|
Lantheus Medical Imaging Completes Enrollment Of CaRES Registry to Further Evaluate DEFINITY(R) in Patients with Suboptimal Echocardiograms
5/28/2009 9:10:42 AM
More...
|
Lantheus Medical Imaging Takes Proactive Steps to Mitigate Impact of Global Molybdenum-99 Supply Crisis on Operations
5/20/2009 11:49:06 AM
More...
|
EPIX Pharmaceuticals, Inc. (EPIX) Announces Sale of U.S., Canadian and Australian Rights for MS-325 to Lantheus Medical Imaging for $28 Million
4/7/2009 7:34:44 AM
More...
|
New Lantheus Medical Imaging Study Finds Significant Survival Benefit for Critically Ill Patients Undergoing Contrast-Enhanced Echocardiography
3/30/2009 10:28:32 AM
More...
|
Lantheus Medical Imaging to Present New Cardiac Imaging Data at the American College of Cardiology 58th Annual Scientific Sessions in Orlando
3/25/2009 10:13:06 AM
More...
|
|